Ibrutinib–Venetoclax Outperforms Ibrutinib Alone and FCR in Long-Term CLL
Ibrutinib combined with venetoclax significantly improved measurable residual disease and progression-free survival in patients with chronic lymphocytic leukemia.
FDA Approves Donidalorsen as First RNA-Targeted Prophylactic Treatment for Hereditary Angioedema
The FDA approves donidalorsen, the first RNA-targeted therapy for hereditary angioedema, offering significant attack reduction and convenient administration.
Study Reveals Why Some Children Still Have Asthma Attacks Even With Treatment
New research uncovers complex inflammatory pathways driving asthma flare-ups in children, highlighting the need for personalized treatment strategies.
Study: High Similarity, Efficacy Between Tocilizumab Biosimilar and Reference Product in RA
New research confirms that switching from tocilizumab to its biosimilar, Avtozma, maintains efficacy and safety in patients with rheumatoid arthritis…
Non-Pharmaceutical Interventions Can Disrupt Dynamics of Pneumococcal Disease
The implementation of non-pharmaceutical measures during the COVID-19 pandemic reduced transmission of Streptococcus pneumoniae, a key bacterium that causes pneumococcal…
American Academy of Pediatrics Releases 2025 Child, Adolescent Immunization Recommendations
The AAP unveiled its 2025 immunization schedule, challenging CDC guidelines and emphasizing evidence-based vaccine recommendations for children’s health.
Advancing Breast Cancer Care: The Role of Palbociclib in HR+/HER2- Disease
Palbociclib revolutionizes HR+/HER2- breast cancer treatment, enhancing outcomes with endocrine therapies and promising new combinations for better patient care.
Probiotic Supplementation in Very-Low-Birth-Weight Preterm Infants Lowers Gut Antibiotic Resistance
Probiotic supplementation in VLBW preterm infants reduces antibiotic resistance and promotes beneficial gut bacteria, enhancing neonatal health outcomes.
Culturally Tailored Education Empowers Patients With Type 1 Diabetes
Simplifying complex information through illustrations and storytelling helps patients feel that managing their condition is achievable.
Translating Trials to Practice: Defining Clinically Meaningful Benefits in mCRC
Panelists discuss how the SUNLIGHT trial’s success stems from its methodical design with robust single-arm and randomized phase two data…